Cardiovascular manifestations of autosomal dominant polycystic kidney disease in young adults

Clinical and Investigative Medicine

Volumn 29, Issue 6, 2006, Pages 339-346

  Handa, S Paul ^a  

^a Atlantic Health Sciences Corporation   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE PREDISPOSITION; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; LABORATORY TEST; M MODE ECHOCARDIOGRAPHY; MALE; PILOT STUDY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; VISCOELASTICITY;

ADULT; AORTA; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; CIRCADIAN RHYTHM; CREATINE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GENES, DOMINANT; HEART RATE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FUNCTION TESTS; MALE; POLYCYSTIC KIDNEY DISEASES; RISK FACTORS;

EID: 33847725921     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Dalgaard OZ. Bilateral polycystic disease of the kidneys : a follow-up of two hundred and eighty-four patients and their families. Acta Med Scand 1957; 328 [Suppl]: 1-255.
2. Iglesias CG, Torres VE, Offord KP, Holley KE, Beard CM, Kurland LT. Eipdemiology of adult polycystic kidney disease, Olmsted County, Minnesota 1935-1980. Am J Kidney Dis 1983; 2: 630-9.
3. Chapman AB, Johnson AM, Rainguet S, Hossack K, Gabow P, Schrier RW. Left ventricular hypertrophy in autosomal dominant polycystic kidnet disease. J Am Soc Nephrol 1997; 8: 1292-7.
4. Bardaj A, Martinez-Vea A, Valero A. Cardiac involvement in autosomal-dominant polycystic kidney disease: A hypertensive heart disease. Clin Nephrol 2001; 56: 211-20.
5. Zeier M, Geberth S, Schmidt KG, Mandelbaum A, Ritz E. Elevated blood pressure profile and left ventricular mass in childreb and young adults with autosomal deominant polycystic kidney disease. J Am Soci Nephrol 1993; 3: 1451-7
6. Martinez-Vea A, Bardaj A, Gutierrez C, et al. Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: A prehypertensive state. Am J Kidney Dis 2004; 442: 1-14.
7. Hossack KF, Leddy CL, Johnson AM, Schrier RW, Gabow PA: Echocardiographic findings in autosomal dominant polycystic kidney disease. N Engl J Med 1988; 319: 907-12.
8. Timio M, Monarca C, Pede S, Gentili S, Verdura C, Lolli S. The spectrum of cardiovascular abnormalities in autosomal dominant polycystic kidney disease: A 10-year follow-up in a five-generation kindred. Clin Nephrol 1992; 37: 245-51.
9. Chauveau D, Pirson Y, Verellen-Dumoulin C, Macnicol AM, Gonzalo A, Grunfeld JP. Intracranial aneurysms in autosomal polycystic kidney disease. Kidney International 1994; 45: 1140-6.
10. Bardaj A, Vea AM, Gutierrez C, Ridao C, Richart C, Oliver JA. Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease. Am J Kidney Dis 1998; 32: 970-5.
11. Mahmoud Loghman-Adham , Carlos E. Soto , Tadashi Inagami , Lisa Cassis. The Intrarenal rennin-angiotensin system in autosomal dominant polycystic kidney disease. AJP- Renal Physiology .2004;287:1775-88.
12. Marjan A, van Dijk , Martijn H. Breuning ., Rik Duiser , Leendert A ,van Es and Rudi G.J. Westendorp . No effect of enalapril on progression in autosomal dominant kidney disease. Nephrology Dialysis Transplantation 2003;18:2314-2320
13. Handa SP, Wong J, Wolf HK. The relationship of plasma norepinephrine levels and aortic distensiblity in elderly with isolated systolic hypertension. Am J Hypertens 1995; 8: 422-5.
14. Stefandis C, Stratos C, Bourdoulos H, Kourouklis C, Toutoyzas P. Distensibility of the ascending aorta: comparison of invasive and noninvasive techniques in health men and in men with coronary artery disease. Eur Heart J 1990; 11: 990-6.
15. Devereux RB, Reichek N. Left ventricular hypertrophy. Cardiovasc Res 1980; 1: 55-61.
16. Pierdomenico SD, Bucci A, Constantini F, et al. Circadian blood pressure changes and myocardial ischemia in hypertensive patients with coronary artery disease. J Am Coll Cardiol 1998; 32: 1627-34.
17. Verdecchia P, Schillaci G, Borgioni C, et al. Altered circadian blood pressure profile and prognosis. Blood Press Monit 1997; 2: 347-52.
18. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67:2089-100.
19. Schrier R, McFann K, Johnson A, et al. Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of seven-year prospective randomized study. J Am Soc Nephrol 2002; 13: 1733-9.
20. Kelleher CL, McMann KK, Johnson AM, Schrier RW. Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population, Am J Hypertens 2004; 17: 1029-34.
21. Andersen MJ, Khawandi W, Agarwal R. Home blood pressure monitoring in CKD. Am J Kidney Dis 2005; 45: 994-1001.
22. Milutinovic J, Fialkon PJ, Agodoa LY, Phillips LA, Ruad TG, Bryant JL. Autosomal dominant polycystic kidney disease. Symptoms and clinical findings. QJ Med 1984; 53: 511-22.
23. Gabow PA, Chapman AB, Johnson AM, et al. Renal structure and hypertension in autosomal dominant polycystic kidney disease. Kidney Int 1990; 38; 1177-80.
24. Covic A, Mititiuc I, Gusbeth-Tatomir P, Goldsmith DJ. The reproducibility of the circadian BP rhythm in treated hypertensive patients with polycystic kidnet disease and mild chronic renal impairment - a prospective ABPM study. J Nephrol 2002; 15: 497-506.
25. Seeman T, Dusek J, Vendrichona H, Kyncl M, John U, Miselwitz J, Janda J. Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease. Blood Pressure Monit 2003; 8: 107-10.
26. Li KWTC, Macnicol AM, Watson ML. Ambulatory blood pressure in hypertensive patients with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 1997; 12: 2075-80.
27. Cerasola G, Vecchi M, Mule G, et al. Sympathetic activity and blood pressure pattern in autosomal dominant polycystic kidney disease hypertensives. Am J Nephrology 1998; 18: 391-8.
28. Liu M, Takahashi, Morita Y, et al. Non-dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in hemodialysis patients. Nephrol Dial Transplant 2003; 18: 563-9.
29. Mercuro G , Zoncu S , Piano D , et al. Estradiol -17 beta reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertension. Am J Hypertens 1998; 11 (8 Pt 1): 909-13.
30. Chapman AB, Shrier RW. Pathogenesis of hypertension in autosomal dominant Polycystic kidney disease. Semin Nephrol 1991;11: 653-60.
31. Saggar-Malik AK, Missouris CG, Gill JS, Singer DRJ, Markandu ND, MacGregor GA. Left ventricular mass in normotensive subjects with autosomal dominant polycystk kidney disease. BMJ 1994; 309: 1617-8.
32. Amann K, Neustib R, Ritz E, Irzyniec T, Weist G, Mall G. Changes of vascular architecture independent of blood pressure in experimental uremia. Am J Hypertens 1995; 8: 409-17.
33. Amann K, Wolf B, Nichols C, et al. Aortic changes in experimental renal failure: hyperplasia or hypertrophy of smooth muscle cells? Hypertension 1997; 29: 770-5.
34. Mourad JJ, Pannier C, Blacher J, et al. Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int 2001; 59: 770-5.
35. Ibels LS, Alfrey AL, Huffer WE, Craswell PW, Anderson TJ, Weil R. Arterial calcifications and pathology in uremic patients undergoing dialysis. Am J Med. 1979; 66: 790-6.
36. London GM, Guerin AP, Pannier B, Safar ME, Day M, Metivier F. Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996; 50: 600-8.
37. Buckberg GD, Towers B, Paglia DE, Mulder DG, Maloney JV. Subendocardial ischemia after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1972; 64: 669-87.
38. Wantanabe H, Phtsuka S, Kaihana M, Sugishita Y. Coronary circulation in dogs with an experimental decrease in aortic compliance. J Am Coll Cardiol 1993; 21: 1497-506.
39. Canadian Organ Replacement Register. Annual report 2004.Ottawa; Canadian institute for Health Information; 2004 (correspondence)
40. Stigant Caroline , Stevens Lesley , Levin Adeera. Nephrology:4. Strategies for the care of adults with chronic kidney disease. Can Med Assoc J. 2003; 168:1553-60
41. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation , classification , and stratification. Kidney Disease Outcome Quality Initiative. Am J. Kidney Dis. 2002; 39 (suppl 2):S1-246